Doctor photo
Specialty :

DR. VIGROM JENNETISIN

SPECIALTY :
  • Oncology

DR. VIGROM JENNETISIN

Educations (with year)

2012

  • Fellowship of Medical Oncology, Ramathibodi Hospital, Mahidol University, 2012

2010

  • Residency of Internal Medicine, Khonkaen Hospital, Khonkaen University, 2010.

2007

  • Doctor of Medicine, Khonkaen University
See more
Board Certifications

2020

  • Certificate of Achievement: HMX Pro Cancer Genomics and Precision Oncology, Harvard Medical School
  • Certificate of Achievement: HMX Pro Immuno-Oncology, Harvard Medical School

2019

  • Certificate of Achievement: HMX Fundamentals – Genetics, Harvard Medical School
  • Certificate of Achievement: HMX Fundamentals – Immunology, Harvard Medical School
See more
Special Clinical Trainings

 

  • Cancer Genomics and Precision Oncology
  • Immuno Oncology / Immune Cell therapy / Cancer vaccine
Special Clinical Interests

 

  • Advanced Technology in Cancer Omics (Multi omics approach)
  • Personalized cancer treatment /  Precision cancer medicine
Conditions Treated (Disease)

 

  • All Solid malignancies : Breast cancer, Lung cancer, Colon cancer, Hepatobiliary cancer etc.
Publications

 

  1. A phase II single-center study of the tolerability and efficacy of TBX-3400 in subjects with chronic HBV or hepatitis virus associated liver tumors resistant or refractory to standard therapies. (Principle Investigator)
  2. Development of patient – derived organoids with accompanying molecular and anti- cancer drug response data for precision oncology. (Co-Investigator)
  3. Development of AI-assisted software for holistic need assessment in cancer patients to promote individualized cancer care. (Principle Investigator)

 

  1. Identification of Immunogenic Personal Tumor-Specific Mutations and Neoantigens from Solid tumor or Liquid biopsy (Principle investigator)
  2. Personalized neoantigen peptide vaccine for cancer treatment (Principle investigator)
See more
Journal Affiliations

2016

  • Correlation of Mitotic Index and Ki-67 and Their Impacts on Survival of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at Ramathibodi Hospital. Annals of Oncology, Volume 27, Supplement 2, June 01, 2016.  Poster Presentation at ESMO World GI Congress, Barcelona, Spain.

2014

  • Prevalence and risk factors for deep vein thrombosis in hospitalized high-risk patients at a tertiary care hospital in Thailand.  Asian Biomedicine Vol.8 No.6, December ; 759 – 762
See more
Professional Membership

 

  • ASCO member since 2012
  • ESMO member since 2012
  • TSCO member since 2012

Clinic Hours

Patient Stories

Videos

Call us at
(+66)8-522 38888
Please select your language